Shares of Pfizer (NYSE:PFE) have bearishly opened below the pivot of $25.20 today and have reached the first support level of $25.08. Should the shares continue to fall, the support pivots of $24.91 and $24.62 will be of interest.
There is potential upside of 11.6% for shares of Pfizer based on a current price of $25.05 and an average consensus analyst price target of $27.95. The stock should find initial support at its 50-day moving average (MA) of $24.97 and further support at its 200-day MA of $23.58.
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
Pfizer share prices have moved between a 52-week high of $26.09 and a 52-week low of $20.75 and are now trading 21% above that low price at $25.05 per share. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has remained constant.